Program Nordic ITP meeting 2025

Friday, 25. april

12.00 - 13.00
Lunch

13.00 - 13.30
Introduction and welcome - what have we achived since we established the Nordic ITP group?
// Waleed Ghanima

13.30 - 15.00
Future collaborative research
Chair: // Stella Wei

Moving ahead with research in the Nordic
// Henrik Frederiksen

Discussions; set-up and funding
// All

A univerisal research registry for ITP: is it possible?
// Waleed Ghanima

Abstract: Predcting the effect of Rituximab: data from the Nordic chronic ITP registry
// Galina Tsykunova

Abstract: Abstract: HRQoL in ITP
// Riccardo Tomasselo

Study proposal: Evaluation of cardiovascular risk in patients with ITP and use of antiagregative/anticoagulant medication
// Nora Butta


15.00 - 15.30
Break

15.30 - 17.30
Clinical update and treatment
Chair: // Terhi Friman

Management of ITP - current and future therapies
// Cecilia Karlström

Real world data on TPO-RA and fostamatinib - how to generate such data in the nordics
// Waleed Ghanima

Highlights from ASH: the results of rilzabrutimib study
// Waleed Ghanima

Update on ongoing study: The Holistic study
// Eirik Tjønnfjord

New study proporsal: TPO-stop study
// Henrik Frederiksen

Abstract: Efficacy and safety of daratumumab in ITP - results of the Dart study
// Galina Tsykunova

Abstract: Age-driven and disease-specific alterations in platelets in ITP
// Nora Butta

19.00 Dinner (Restaurant located on the top floor)


Saturday, 26. april

08.00 - 09.30
ITP biology update and research Chair: // John Semple

Pathophsyiology knowns and unknowns
// Rick Kapur

miRNA - a biomarker for ITP - ongoing study and prelimanry results
// Anbjørg Rangberg

The mistery of thrombosis in ITP? How do ITP drugs affect the coagulation? Upcoming study
// Lamya Garabet

A closer look at T-cells
// Nichola Cooper

Abstract: Daratumumab effect on the immune system- results from the DART study
// Ludvig Munthe


09.30 - 10.00
Break

10.00 - 11.30
ITP dignostics: status and research Chair: // Eva Zetterberg

Antiplatelet antibodies; should be done or not?
// Marie Therese Ahlen

ITP - WGS project
// Eva Lienøe

Abstract: First diagnosed with ITP and delvelopment of SLE
// Malin Rasmussen

How should we diagnose adult ITP in the Nordics - a project to harmonize the diagnostic work up
// Alexandros Arvanitakis

New study proporsal: a combination study for the refractory
// Eva Mingot

11.30 - 11.45
Break

11.45 - 12.00
Update from ITP patient group
// Marie Linden

12.00 - 13.00
ITP groups - summary and future plans

13.00 - 14.00
Lunch